Vascular endothelial growth factor

Results: 606



#Item
31What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:09:11
32What Have Sequencing Trials Taught Us? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy

What Have Sequencing Trials Taught Us? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:45
33Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Add to Reading List

Source URL: www.novartis.ca

Language: English - Date: 2015-05-13 10:22:10
34New target: FGFR & c-MET Laurence Albiges Gustave Roussy Institute, Dana-Farber Cancer Institute  New target : FGFR, c-MET

New target: FGFR & c-MET Laurence Albiges Gustave Roussy Institute, Dana-Farber Cancer Institute New target : FGFR, c-MET

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:47
35New Targets to Reverse VEGF Resistance Prof. Eric Raymond, MD, PhD Head of Medical Oncology UNIL-CHUV – Lausanne - Switzerland

New Targets to Reverse VEGF Resistance Prof. Eric Raymond, MD, PhD Head of Medical Oncology UNIL-CHUV – Lausanne - Switzerland

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:42
36This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar

Add to Reading List

Source URL: en.actc-lab.chem.uoa.gr

Language: English - Date: 2012-03-25 13:29:56
37FOR IMMEDIATE RELEASE Aerpio Therapeutics Initiates Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Diabetic Macular Edema Cincinnati, OH, February 13, 2014 – Aerpio Therapeutics, Inc., a clinical-stage b

FOR IMMEDIATE RELEASE Aerpio Therapeutics Initiates Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Diabetic Macular Edema Cincinnati, OH, February 13, 2014 – Aerpio Therapeutics, Inc., a clinical-stage b

Add to Reading List

Source URL: www.aerpio.com

Language: English - Date: 2014-02-13 16:12:56
38PNAS PLUS  Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna

PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna

Add to Reading List

Source URL: www.pnas.org

Language: English - Date: 2015-05-22 15:03:31
39Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:25:25
40Research Article  Human Vascular Model with Defined Stimulation Medium – A Characterization Study Outi Huttala *1, Hanna Vuorenpää *1, Tarja Toimela 1, Jukka Uotila 2, Hannu Kuokkanen 3,

Research Article Human Vascular Model with Defined Stimulation Medium – A Characterization Study Outi Huttala *1, Hanna Vuorenpää *1, Tarja Toimela 1, Jukka Uotila 2, Hannu Kuokkanen 3,

Add to Reading List

Source URL: altweb.jhsph.edu

Language: English